Integrating pharmacies into public health program planning for pandemic influenza vaccine response.
During an influenza pandemic, to achieve early and rapid vaccination coverage and maximize the benefit of an immunization campaign, partnerships between public health agencies and vaccine providers are essential. Immunizing pharmacists represent an important group for expanding access to pandemic vaccination. However, little is known about nationwide coordination between public health programs and pharmacies for pandemic vaccine response planning.



To assess relationships and planning activities between public health programs and pharmacies, we analyzed data from Centers for Disease Control and Prevention assessments of jurisdictions that received immunization and emergency preparedness funding from 2012 to 2015.



Forty-seven (88.7%) of 53 jurisdictions reported including pharmacies in pandemic vaccine distribution plans, 24 (45.3%) had processes to recruit pharmacists to vaccinate, and 16 (30.8%) of 52 established formal relationships with pharmacies. Most jurisdictions plan to allocate less than 10% of pandemic vaccine supply to pharmacies.



While most jurisdictions plan to include pharmacies as pandemic vaccine providers, work is needed to establish formalized agreements between public health departments and pharmacies to improve pandemic preparedness coordination and ensure that vaccinating pharmacists are fully utilized during a pandemic.
IHRC, Inc, Atlanta, GA, United States; Oak Ridge Institute for Science and Education, Oak Ridge, TN, United States; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States. Electronic address: ymi8@cdc.gov.
Thomas J
TJ
Fitzgerald
Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Yoonjae
Y
Kang
Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Carolyn B
CB
Bridges
Division of State and Local Readiness, Office of Public Health Preparedness and Response, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Todd
T
Talbert
Division of State and Local Readiness, Office of Public Health Preparedness and Response, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Sara J
SJ
Vagi
Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Brock
B
Lamont
Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Samuel B
SB
Graitcer
D002487:Centers for Disease Control and Prevention, U.S.; D002959:Civil Defense / Q000191:economics / Q000706:statistics & numerical data; D019033:Delivery of Health Care, Integrated; D004189:Disaster Planning / Q000706:statistics & numerical data; D006801:Humans; D007114:Immunization; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology; D007252:Influenza Vaccines / Q000008:administration & dosage; D007251:Influenza, Human / Q000517:prevention & control*; D058873:Pandemics / Q000517:prevention & control*; D010594:Pharmacies; D010595:Pharmacists; D011634:Public Health; D014481:United States; D000073887:Vaccination Coverage
D007252:Influenza Vaccines
Disaster Med Public Health Prep. 2011 Dec;5(4):253-5
22146661
Vaccine. 2012 Dec 17;31(1):196-201
23123022
MMWR Recomm Rep. 2014 Sep 26;63(RR-06):1-18
25254666
Disaster Med Public Health Prep. 2012 Mar;6(1):44-52
22490936
Disaster Med Public Health Prep. 2011 Dec;5(4):300-8
22146669
Clin Infect Dis. 2015 May 1;60 Suppl 1:S20-9
25878298
J Am Pharm Assoc (2003). 2003 Nov-Dec;43(6):694-701
14717266